1.0800
-0.0300
(-2.70%)
As of 8:08:55 AM GMT+2. Market Open.
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
10,908
10,908
10,023
10,162
10,649
Cost of Revenue
98
98
212
257
533
Gross Profit
10,810
10,810
9,811
9,905
10,116
Operating Expense
55,352
55,352
58,143
62,925
52,181
Operating Income
-44,542
-44,542
-48,332
-53,020
-42,065
Net Non Operating Interest Income Expense
1,153
1,153
919
-3,652
-4,261
Other Income Expense
1,153
--
--
--
890
Pretax Income
-43,389
-43,389
-47,413
-56,672
-45,436
Net Income Common Stockholders
-43,389
-43,389
-47,413
-56,672
-45,436
Diluted NI Available to Com Stockholders
-43,389
-43,389
-47,413
-56,672
-45,436
Basic EPS
-6.88
--
-8.96
-12.20
-10.00
Diluted EPS
-6.88
--
-8.96
-12.20
-10.00
Basic Average Shares
6,306.2840
--
5,293.2940
4,669.6250
4,578.4570
Diluted Average Shares
6,306.2840
--
5,293.2940
4,669.6250
4,578.4570
Total Operating Income as Reported
-44,542
-44,542
-48,332
-53,020
-42,065
Rent Expense Supplemental
--
--
--
--
617
Total Expenses
55,450
55,450
58,355
63,182
52,714
Net Income from Continuing & Discontinued Operation
-43,389
-43,389
-47,413
-56,672
-45,436
Normalized Income
-43,389
-43,389
-47,413
-56,672
-45,436
Interest Income
1,768
1,768
2,938
1,119
211
Interest Expense
615
615
2,019
4,771
4,472
Net Interest Income
1,153
1,153
919
-3,652
-4,261
EBIT
-42,774
-42,774
-45,394
-51,901
-40,964
EBITDA
-42,571
-42,571
-45,139
-51,668
-40,806
Reconciled Cost of Revenue
98
98
212
257
533
Reconciled Depreciation
203
203
255
233
158
Net Income from Continuing Operation Net Minority Interest
-43,389
-43,389
-47,413
-56,672
-45,436
Normalized EBITDA
-42,571
-42,571
-45,139
-51,668
-40,806
12/31/2021 - 12/28/2007
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
SLNCF Silence Therapeutics plc
0.8500
0.00%
GYRE Gyre Therapeutics, Inc.
7.48
+8.09%
PROK ProKidney Corp.
0.5893
-1.67%
PLRZ Polyrizon Ltd.
0.3700
+6.84%
INZY Inozyme Pharma, Inc.
0.8993
+9.51%
SEPN Septerna, Inc.
5.37
-2.01%
GUTS Fractyl Health, Inc.
1.0200
-8.93%
BCDA BioCardia, Inc.
2.0000
-0.50%
LYRA Lyra Therapeutics, Inc.
0.1104
-8.55%
ELEV Elevation Oncology, Inc.
0.2371
-5.16%